Department of Anatomy, Physiology, and Cell Biology, University of California Davis School of Veterinary Medicine, Davis, CA 95616, USA.
Neurogastroenterol Motil. 2011 Jul;23(7):e282-93. doi: 10.1111/j.1365-2982.2011.01673.x. Epub 2011 Feb 9.
Lumenal glucose initiates changes in gastrointestinal (GI) function, including inhibition of gastric emptying, stimulation of pancreatic exocrine and endocrine secretion, and intestinal fluid secretion. Glucose stimulates the release of GI hormones and 5-hydroxytryptamine (5-HT), and activates intrinsic and extrinsic neuronal pathways to initiate changes in GI function. The precise mechanisms involved in luminal glucose-sensing are not clear; studying gut endocrine cells is difficult due to their sparse and irregular localization within the epithelium.
Here we show a technique to determine activation of gut epithelial cells and the gut-brain pathway in vivo in rats using immunohistochemical detection of the activated, phosphorylated, form of calcium-calmodulin kinase II (pCaMKII).
Perfusion of the gut with glucose (60 mg) increased pCaMKII immunoreactivity in 5-HT-expressing enterochromaffin (EC) cells, cytokeratin-18 immunopositive brush cells, but not in enterocytes or cholecystokinin-expressing cells. Lumenal glucose increased pCaMKII in neurons in the myenteric plexus and nodose ganglion, nucleus of the solitary tract, dorsal motor nucleus of the vagus and the arcuate nucleus. pCaMKII expression in neurons, but not in EC cells, was significantly attenuated by pretreatment with the 5-HT(3) R antagonist ondansetron. Deoxynojirimycin, a selective agonist for the putative glucose sensor, sodium-glucose cotransporter-3 (SGLT-3), mimicked the effects of glucose with increased pCaMKII in ECs and neurons; galactose had no effect.
CONCLUSIONS & INFERENCES: The data suggest that native EC cells in situ respond to glucose, possibly via SGLT-3, to activate intrinsic and extrinsic neurons and thereby regulate GI function.
腔内分泌的葡萄糖会引起胃肠(GI)功能的变化,包括抑制胃排空、刺激胰腺外分泌和内分泌分泌以及肠道液体分泌。葡萄糖会刺激 GI 激素和 5-羟色胺(5-HT)的释放,并激活内在和外在神经元途径,从而引发 GI 功能的变化。腔内葡萄糖感应的确切机制尚不清楚;由于肠内分泌细胞在上皮细胞中的分布稀疏且不规则,因此研究这些细胞具有一定难度。
本研究通过免疫组织化学检测激活的、磷酸化的钙调蛋白激酶 II(pCaMKII)的形式,展示了一种在大鼠体内确定肠上皮细胞和肠-脑途径激活的技术。
用葡萄糖(60mg)灌流肠道会增加 5-HT 表达的肠嗜铬细胞(EC)、细胞角蛋白 18 免疫阳性刷状细胞中 pCaMKII 的免疫反应性,但不会增加肠细胞或胆囊收缩素表达细胞中的 pCaMKII。腔内葡萄糖会增加肌间神经丛和迷走神经节、孤束核、迷走神经背核和弓状核中的神经元中的 pCaMKII。5-HT(3)R 拮抗剂昂丹司琼预处理会显著减弱神经元而非 EC 细胞中的 pCaMKII 表达。脱氧野尻霉素是假定的葡萄糖传感器、钠-葡萄糖协同转运蛋白-3(SGLT-3)的选择性激动剂,可增加 EC 细胞和神经元中的 pCaMKII,从而模拟葡萄糖的作用;而半乳糖则没有作用。
数据表明,原位 EC 细胞可能通过 SGLT-3 对葡萄糖作出反应,以激活内在和外在神经元,从而调节 GI 功能。